Ayush Ministry Gets Rs 3,712 Crore In Interim Budget

New Delhi: The interim Budget allocation for the Ayush Ministry has been increased to Rs 3,712.49 crore for 2024-25 from Rs 3,000 crore (revised estimates) in 2023-24, recording a rise of 23.74 percent.

The National Medicinal Plants Board has been allocated Rs 14.63 crore while the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) allocated Rs 20.80 crore.

The autonomous bodies have been allocated Rs 1,848.40 crore, of which Central Council for Research in Ayurvedic Sciences has been given Rs 413.54 crore, Central Council for Research in Homeopathy Rs 144 crore, Central Council for Research in Unani Medicine Rs 228.05 crore and the All India Institute of Ayurveda has got Rs 227.20 crore.

The National Medicinal Plants Board undertakes promotional and contractual farming schemes with a view to encourage in-situ conservation and ex-situ cultivation of medicinal plants for providing raw materials of assured quality for manufacturing of ASU&H medicines.

At the initiative of the National Medicinal Plants Board, 32 State Medicinal Plants Boards in 27 states and five Union territories have been constituted for providing impetus to cultivation of high priority medicinal plants for domestic consumption as well as export.

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy is a subordinate office under the Ministry of Ayush. It is an appellate authority for drug testing of all Ayush drugs in India. Further, it sets standards for all Ayush drugs which are published in the form of Pharmacopoeias.

Related Posts

TG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904

In a swift enforcement action against the unauthorized distribution of habit-forming medications, officials from the Drug Control Wing under the Telangana Standards Authority for Food and Essential Drugs (TG SAFE)…

FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd

According to the FDA commissioner, the aim of the FDA is not merely to take regulatory action, but to ensure the safety and quality of medicines and statutory compliance throughout…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

TG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904

TG SAFE drug wing raids medical shop in Sangareddy, seizes illegal tramadol worth Rs. 58,904

FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd

FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd

At least five workers killed in boiler explosion at pharma unit in Andhra Pradesh’s Sri City SEZ

At least five workers killed in boiler explosion at pharma unit in Andhra Pradesh’s Sri City SEZ

Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in Bihar

Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in Bihar